LU84357A1 - Formulations pharmaceutiques comprenant de l'insuline humaine,un c-peptide humain et de la pro-insuline humaine - Google Patents
Formulations pharmaceutiques comprenant de l'insuline humaine,un c-peptide humain et de la pro-insuline humaine Download PDFInfo
- Publication number
- LU84357A1 LU84357A1 LU84357A LU84357A LU84357A1 LU 84357 A1 LU84357 A1 LU 84357A1 LU 84357 A LU84357 A LU 84357A LU 84357 A LU84357 A LU 84357A LU 84357 A1 LU84357 A1 LU 84357A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- human
- insulin
- pro
- peptide
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29671681A | 1981-08-27 | 1981-08-27 | |
| US29671681 | 1981-08-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU84357A1 true LU84357A1 (fr) | 1983-02-28 |
Family
ID=23143244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU84357A LU84357A1 (fr) | 1981-08-27 | 1982-08-26 | Formulations pharmaceutiques comprenant de l'insuline humaine,un c-peptide humain et de la pro-insuline humaine |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JPS5846026A (sv) |
| AU (1) | AU551734B2 (sv) |
| BE (1) | BE894187A (sv) |
| CA (1) | CA1176159A (sv) |
| CH (1) | CH650680A5 (sv) |
| DE (1) | DE3232035A1 (sv) |
| FR (1) | FR2511868B1 (sv) |
| GB (1) | GB2104381B (sv) |
| IL (1) | IL66612A (sv) |
| IT (1) | IT1153183B (sv) |
| LU (1) | LU84357A1 (sv) |
| MW (1) | MW3982A1 (sv) |
| NL (1) | NL8203313A (sv) |
| NZ (1) | NZ201685A (sv) |
| PH (1) | PH18640A (sv) |
| SE (1) | SE8204872L (sv) |
| ZA (1) | ZA826160B (sv) |
| ZW (1) | ZW17682A1 (sv) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652548A (en) * | 1981-08-27 | 1987-03-24 | Eli Lilly And Company | Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin |
| DE3326473A1 (de) * | 1983-07-22 | 1985-01-31 | Hoechst Ag, 6230 Frankfurt | Pharmazeutisches mittel zur behandlung des diabetes mellitus |
| JPS62222379A (ja) * | 1986-03-25 | 1987-09-30 | Mutoh Ind Ltd | コンピュータグラフィックスにおける隠線・隠面処理方法 |
| US9389582B2 (en) | 2014-06-02 | 2016-07-12 | Lexmark International, Inc. | Replaceable unit for an image forming device having magnets of varying angular offset for toner level sensing |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2789080A (en) * | 1952-08-14 | 1957-04-16 | Christensen Henry Marinus | Insulin-albumin compositions |
| CH330318A (de) * | 1953-09-08 | 1958-05-31 | British Drug Houses Ltd | Verfahren zur Herstellung eines Insulinpräparates mit verlängerter Wirkungszeit |
-
1982
- 1982-08-23 CH CH5011/82A patent/CH650680A5/de not_active IP Right Cessation
- 1982-08-23 IL IL66612A patent/IL66612A/xx unknown
- 1982-08-23 CA CA000409911A patent/CA1176159A/en not_active Expired
- 1982-08-23 ZW ZW176/82A patent/ZW17682A1/xx unknown
- 1982-08-24 BE BE6/47703A patent/BE894187A/fr not_active IP Right Cessation
- 1982-08-24 PH PH27769A patent/PH18640A/en unknown
- 1982-08-24 NL NL8203313A patent/NL8203313A/nl not_active Application Discontinuation
- 1982-08-24 NZ NZ201685A patent/NZ201685A/xx unknown
- 1982-08-24 MW MW39/82A patent/MW3982A1/xx unknown
- 1982-08-24 ZA ZA826160A patent/ZA826160B/xx unknown
- 1982-08-25 JP JP57148496A patent/JPS5846026A/ja active Pending
- 1982-08-25 AU AU87597/82A patent/AU551734B2/en not_active Ceased
- 1982-08-25 FR FR8214596A patent/FR2511868B1/fr not_active Expired
- 1982-08-25 SE SE8204872A patent/SE8204872L/sv not_active Application Discontinuation
- 1982-08-26 LU LU84357A patent/LU84357A1/fr unknown
- 1982-08-26 GB GB08224483A patent/GB2104381B/en not_active Expired
- 1982-08-27 IT IT23018/82A patent/IT1153183B/it active
- 1982-08-27 DE DE19823232035 patent/DE3232035A1/de not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA1176159A (en) | 1984-10-16 |
| IT1153183B (it) | 1987-01-14 |
| PH18640A (en) | 1985-08-23 |
| CH650680A5 (de) | 1985-08-15 |
| FR2511868A1 (fr) | 1983-03-04 |
| NL8203313A (nl) | 1983-03-16 |
| JPS5846026A (ja) | 1983-03-17 |
| SE8204872L (sv) | 1983-02-28 |
| SE8204872D0 (sv) | 1982-08-25 |
| DE3232035A1 (de) | 1983-03-10 |
| ZA826160B (en) | 1984-04-25 |
| AU551734B2 (en) | 1986-05-08 |
| NZ201685A (en) | 1985-09-13 |
| BE894187A (fr) | 1983-02-24 |
| FR2511868B1 (fr) | 1986-05-09 |
| MW3982A1 (en) | 1984-06-13 |
| AU8759782A (en) | 1983-03-03 |
| ZW17682A1 (en) | 1982-11-24 |
| IT8223018A0 (it) | 1982-08-27 |
| IL66612A (en) | 1985-11-29 |
| GB2104381B (en) | 1984-12-05 |
| GB2104381A (en) | 1983-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1009408A5 (fr) | Formulations d'analogues de l'insuline. | |
| JP4426727B2 (ja) | 新規なエキセンジンアゴニスト製剤とその投与方法 | |
| US7381702B2 (en) | Methods of treating diabetes mellitus | |
| LU84356A1 (fr) | Formulations pharmaceutiques comprenant de l'insuline et de la pro-insuline humaines | |
| ZA200406332B (en) | ACC inhibitors. | |
| DE69022501T2 (de) | Verwendung eines Amylinantagonisten zur Herstellung eines Artzneimittels zur Behandlung von Fettsucht und essentieller Hypertonie und damit zusammenhängenden Krankheiten. | |
| LU84359A1 (fr) | Formulations pharmaceutiques comprenant de l'insuline humaine et du c-peptide humain | |
| US4652548A (en) | Pharmaceutical formulations comprising human insulin, human C-peptide, and human proinsulin | |
| US20040038867A1 (en) | Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus | |
| CN111712236A (zh) | 用于治疗糖尿病的包含基于脂质的纳米颗粒的组合物 | |
| LU84358A1 (fr) | Formulations pharmaceutiques de pro-insuline humaine | |
| LU84357A1 (fr) | Formulations pharmaceutiques comprenant de l'insuline humaine,un c-peptide humain et de la pro-insuline humaine | |
| KR20200130297A (ko) | 비만의 치료 및 체중 관리를 위한 glp-1 조성물 | |
| Hussain et al. | Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity | |
| BE1013507A5 (fr) | Formulations d'analogues de l'insuline. | |
| KR20220125254A (ko) | 2형 당뇨병에서 만성 신장 질환 및 당뇨병성 신장 질환의 치료를 위한 글루카콘 및 glp-1 공효능제 | |
| FR2746313A1 (fr) | Utilisation de la melatonine et des ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention et au traitement du diabete et des complications diabetiques | |
| Agarwal et al. | Modulators of insulin action | |
| Wideman | Effects of arginine and GHRP-2 infusion on GH release during exercise |